Non-antibiotic Infection Prevention Prevent-Plus offers an FDA-cleared liquid polymer that kills microbes on contact and forms a biodegradable barrier to protect wounds, presenting a non-antibiotic solution for infection prevention and healing that can appeal to clinics, athletic programs, and consumer markets seeking safer alternatives.

Direct-to-Athlete Access Product is positioned for direct-to-consumer use by athletes, athletic trainers, and parents, signaling sales opportunities with youth and school sports programs, sports medicine clinics, and athletic organizations seeking easy-wedge products for wound care.

Compact Team with Big Potential Small team size (2-10 employees) and revenue under one million indicate a lean operation with high impact potential for scalable partnerships, white-labeling, or distribution agreements to accelerate market reach without heavy overhead.

Clinical Validation Advantage Claims are backed by strong scientific and clinical data, which can be leveraged in pitches to hospitals, urgent care centers, and sports medicine groups that require evidence-based solutions for infection control and healing protocols.

Early Expansion Milestone Launch of DuraDerm SPORT in early 2021 signals a growth-oriented mindset and potential for B2B collaborations with sports teams, clinics, and retailers aligned with performance and recovery products.